Millett et al., 1995 - Google Patents
Synthetic function and regulation of osteoblasts: current knowledge and applicationsMillett et al., 1995
View PDF- Document ID
- 17068336246893116689
- Author
- Millett P
- Allen M
- Rushton N
- Publication year
- Publication venue
- McGill Journal of Medicine
External Links
Snippet
In 1886, the histologist Julius Wolff proposed that" every change in the function of a bone is followed by certain definite changes in internal architecture and external conformation in accordance with mathematical principles"(1). Wolff's hypothesis that" form follows function" …
- 210000000963 osteoblast 0 title abstract description 57
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1841—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hernández-Gil et al. | Physiological bases of bone regeneration II. The remodeling process | |
| Raisz | Bone cell biology: new approaches and unanswered questions | |
| Gasser et al. | Bone physiology and biology | |
| Liang et al. | Bone anabolic effects of basic fibroblast growth factor in ovariectomized rats | |
| Erlebacher et al. | Osteoblastic responses to TGF-β during bone remodeling | |
| Hauschka et al. | Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone | |
| Hollinger et al. | Bone tissue engineering | |
| Avioli et al. | Metabolic bone disease and clinically related disorders | |
| Kawaguchi et al. | Acceleration of fracture healing in nonhuman primates by fibroblast growth factor-2 | |
| Kobayashi et al. | Recombinant human bone morphogenetic protein-2 stimulates osteoblastic differentiation in cells isolated from human periodontal ligament | |
| Sommer et al. | The phosphatonins and the regulation of phosphate transport and vitamin D metabolism | |
| Gruber et al. | Effects of cartilage-derived morphogenetic proteins and osteogenic protein-1 on osteochondrogenic differentiation of periosteum-derived cells | |
| Kawasaki et al. | Effects of recombinant human bone morphogenetic protein-2 on differentiation of cells isolated from human bone, muscle, and skin | |
| Giannobile et al. | Non-coordinate control of bone formation displayed by growth factor combinations with IGF-I | |
| Collignon et al. | Isolation of cells from ovine fetal long bone and characterization of their osteoblastic activities during in vitro mineralization | |
| Tamura et al. | The effects of transplantation of osteoblastic cells with bone morphogenetic protein (BMP)/carrier complex on bone repair | |
| Grasser et al. | BMP-6 exerts its osteoinductive effect through activation of IGF-I and EGF pathways | |
| Staal et al. | Regulation of osteocalcin production and bone resorption by 1, 25‐dihydroxyvitamin D3 in mouse long bones: Interaction with the bone‐derived growth factors TGF‐β and IGF‐I | |
| Józsa et al. | Lack of pituitary adenylate cyclase–activating polypeptide (PACAP) disturbs callus formation | |
| Millett et al. | Synthetic function and regulation of osteoblasts: current knowledge and applications | |
| Marie | Osteoblasts and bone formation | |
| Rosen | Anatomy, physiology and disease | |
| Farquharson et al. | Mitogenic action of insulin-like growth factor-I on human osteosarcoma MG-63 cells and rat osteoblasts maintained in situ: the role of glucose-6-phosphate dehydrogenase | |
| Rowe et al. | Enhanced production of mineralized nodules and collagenous proteins in vitro by calcium ascorbate supplemented with vitamin C metabolites | |
| US8066980B2 (en) | Osteogenic synthetic peptides, pharmaceutical compositions comprising the same, and medium containing the same |